Pharma Friday – November 13, 2026

Published on November 13, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences On Nov. 9, Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it has […]

The post Pharma Friday – November 13, 2026 appeared first on Endocrine News.

Continue reading on website
Other news

Looking Across the Organs: Diabetes After Transplant

November 13, 2026
Cross-organ research examines how preexisting diabetes and new-onset diabetes affect survival after kidney, liver, heart, and lung transplantation. Research presented at ENDO 2026 last June highlights distinct organ-specific risks and calls for prevention, monitoring, and long-term care beyond the transplant procedure itself. The presence of diabetes negatively impacts almost any co-occurring heal